Kelyniam Global, Inc. KLYG
Set alert
At close · Oct 30
- YTD
- -16.67%
- 1 year
- -44.44%
- Open
- 0.10
- Prev close
- 0.10
- Mkt cap
- 5.06M
- Vol
- 800
- Avg vol
- 3.56K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.10
- High
- 0.10
News
2 months ago accessnewswire.com
Kelyniam Global Announces Q2 2026 Financial Results
CANTON, CT / ACCESS Newswire / August 11, 2026 / Kelyniam Global (OTCID:KLYG), a leader in custom cranial implants, today reported its financial results for the six months ended June 30, 2026. The…
5 months ago gurufocus.com
Kelyniam Global to Present at Planet MicroCap Las Vegas 2026 - From Single Product to Regenerative Medicine Leader
Kelyniam Global to Present at Planet MicroCap Las Vegas 2026 - From Single Product to Regenerative Medicine Leader PR Newswire
5 months ago prnewswire.com
Kelyniam Global to Present at Planet MicroCap Las Vegas 2026 - From Single Product to Regenerative Medicine Leader
COLLINSVILLE, Conn., June 1, 2026 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leader in patient-specific cranial and craniofacial implants, today announced it will present at the Planet…
5 months ago prnewswire.com
Kelyniam Global Announces Strong Q1 2026 Financial Results
CANTON, Conn., May 11, 2026 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a leader in custom cranial implants, today reported its financial results for the first quarter ended March 31, 2026.
7 months ago prnewswire.com
Kelyniam Global Reports 2025 Financial Results
Strong Second-Half Momentum Drives 85% Net Loss Improvement; FDA Clearance Secured for Innovative Fusion™ Biomaterial Implant; Board Rejects Undervalued Acquisition Interest CANTON, Conn., March 16,…
11 months ago prnewswire.com
Kelyniam Global Announces Q3 2025 Financial Results
CANTON, Conn. , Nov. 10, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leader in custom cranial and craniofacial implants, today reported financial results for the third quarter ended…
12 months ago globenewswire.com
Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products
CANTON, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and cranio-maxillofacial implants, today announced the renewal of its…
1 year ago prnewswire.com
Kelyniam Global, Inc. Receives FDA Clearance for Innovative Fusion™ BCP-PEEK Implant
CANTON, Conn. , Sept. 18, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (Kelyniam), a leading provider of custom cranial and craniofacial implant solutions, announced today that it has received 510(k)…
1 year ago prnewswire.com
Kelyniam Global Inc. to Present at the Life Sciences Virtual Investor Forum September 18th
The Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com CANTON, Conn. , Sept. 15, 2025 /PRNewswire/ --…
1 year ago prnewswire.com
Commitment to Investor
Excellence Kelyniam Global, Inc. Uplists to OTCID Market Tier CANTON, Conn. , Sept. 8, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and…
1 year ago prnewswire.com
Kelyniam Global Announces Q2 2025 Financial Results
CANTON, Conn. , Aug. 11, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the half…
1 year ago prnewswire.com
Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership
CANTON, Conn. , May 12, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the first…
1 year ago prnewswire.com
KELYNIAM ACHIEVES RECORD REVENUE & PROFITABILITY FOR 2024
CANTON, Conn. , March 17, 2025 /PRNewswire/ -- Kelyniam Global (OTC:KLYG), a manufacturer of custom cranial implants, has announced its financial results for the year ended December 31, 2024.
1 year ago prnewswire.com
Kelyniam Global, Inc., ("KLYG") Announces Private Investment to Public Entity ("PIPE") Closure of Securities Offering
Proceeds to Further Growth Objectives in 2025 CANTON, Conn. , Dec. 16, 2024 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced that it has completed the…
1 year ago prnewswire.com
Kelyniam Global Releases Q3 Financials, Strong Performance Continues
CANTON, Conn. , Nov. 11, 2024 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for the third quarter ended September 30, 2024.
2 years ago prnewswire.com
Kelyniam Global Releases Strong Q2 Financials
CANTON, Conn. , Aug. 12, 2024 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for its half year ended June 30, 2024.
2 years ago prnewswire.com
Kelyniam Global Releases Q1 Financials
Announces Shareholder Meeting CANTON, Conn. , May 13, 2024 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for its quarter ended March 31,…
2 years ago prnewswire.com
NEOS Cranial LOOP™ Receives FDA Clearance for CustomizedBone™ Use
CANTON, Conn. , April 2, 2024 /PRNewswire/ -- Kelyniam Global (OTC:KLYG) and Fin-ceramica, Faenza S.p.a.
2 years ago prnewswire.com
Strong Fourth Quarter Powers 2023 Kelyniam Financials
CANTON, Conn. , March 17, 2024 /PRNewswire/ -- Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its year ended December 31, 2023.
2 years ago prnewswire.com
Kelyniam Global Releases 3rd Quarter 2023 Financials
CANTON, Conn. , Dec. 21, 2023 /PRNewswire/ -- Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its third quarter ended September 30, 2023.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Tuesday